Red eyes first sign of the sickle cell disease
AbstractA patient with red eyes and ocular decongestants drops (tetrahidrozolyne 0.05%) use history, was observed by an optometrist and referred to an ophthalmic consult. The redness of their eyes was secondary to conjunctival vessel micro-hemorraghe (petechiaes). After a complete ophthalmology and hematologist exploration a Cell Sickle Disease was diagnosed as the cause of the vascular disorder. An hematologist treat it and the ocular redness was resolved. This case emphasizes the problem about self-medication and remark the importance of the optometrist working together with the ophthalmologist to prevent ocular complains as well as systemic disease.
Leibowitz HM. The red eye. N Engl J Med 2000;343:345-51.
Tappeiner C, Sarra GM, Abegg M. Abuse of vasoconstrictive eyedrops mimicking an ocular pemphigoid. Eur J Ophthalmol 2009;19:129-32.
Xuan B, Chiou GC. Efficacy of oxymetazoline eye drops in non-infectious conjunctivitis, the most common cause of acute red eyes. J Ocul Pharmacol Ther 1997;13:363-7.
Spiller H, Griffith J. Prolonged cardiovascular effects after unintentional ingestion of tetraydrozoline. Clin Toxicol (Phila) 2008;46:171-2.
Ramey JT, Bailen E, Lochey RF. Rhinitis medicamentosa. J Investig Allergol Clin Immunol 2006;16:148-55.
Rahimi Z, Parsian A. Sickle cell disease and venous thromboembolism. Mediterr J Hematol Infect Dis 2011;3:e2011024.
Penman AD, Talbot JF, Chuang EL, et al. New classification of peripheral retinal vascular changes in sickle cell disease. Br J Ophthalmol 1994;78:681-9.
Torres AF, Eberle SE, Sciuccati G, Bonduel M. Effect of hydroxyurea on hemoglobin S. Medicina (B Aires) 2003;63:140-2.
- Abstract views: 777
- PDF: 1075
Copyright (c) 2011 Rodrigo Martín Torres, Pablo Gabriel Lódolo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.